POEM Safe and Effective for Pediatric Achalasia, Study Finds

POEM showed promising safety and efficacy as a treatment for achalasia in children in a single-center ...

MAY 6, 2025

Vancomycin Linked to IBD Remission in Patients With Primary Sclerosing Cholangitis

Children with primary sclerosing cholangitis–associated inflammatory bowel disease may benefit from prolonged ...

SEPTEMBER 3, 2024

Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS

The FDA has approved Lutathera for certain pediatric patients with gastroenteropancreatic neuroendocrine tumors.

APRIL 24, 2024

EGD and Colonoscopy in Children With Cognitive/Developmental Disabilities

Pre-procedure preparation can entail significant potential challenges in children with intellectual and ...

APRIL 5, 2024

Total Wall Thickness Is Emerging as a Diagnostic for Pediatric EoE

Both endoscopic ultrasound and the endoluminal functional lumen imaging probe are being evaluated for assessing ...

MARCH 18, 2024

FDA Approves Maralixibat for Cholestatic Pruritus in PFIC

The FDA approved maralixibat (Livmarli, Mirum) for cholestatic pruritus in patients 5+ years with PFIC.

MARCH 15, 2024

Guidelines for Managing Children With GI Varices Often Not Followed

Pediatric guidelines recommend that children with gastrointestinal varices undergo endoscopic treatment, but not ...

FEBRUARY 29, 2024

Pilot Study Explores Screening of Newborns for Wilson’s Disease

Testing newborns for Wilson’s disease soon may be feasible and effective at a public health level.

FEBRUARY 27, 2024

A Simple Test Avoids EoE Misdiagnosis, Treatment

Eosinophil-derived neurotoxin is a practical, simple and useful biomarker for eosinophilic esophagitis, according ...

FEBRUARY 14, 2024

FDA Approves First Oral Budesonide for EoE

The FDA approved the first oral suspension of budesonide (Eohilia, Takeda) for patients with eosinophilic ...

FEBRUARY 12, 2024

FDA Expands Dupilumab EoE Indication to Children as Young as 1 Year

The FDA expanded the indications for dupilumab (Dupixent, Regeneron/Sanofi) to include treatment of children with ...

JANUARY 26, 2024

When to Start Enteral Nutrition in Patients With GI Disease

Clinicians should consider starting enteral nutrition as soon as there is a risk for malnutrition due to inadequate ...

NOVEMBER 29, 2023